Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease
Clinical trial NCT06876363 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06876363
- Sponsor
- Ensoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-05
- Primary completion
- 2027-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.